SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001210
Filing Date
2023-05-15
Accepted
2023-05-15 16:05:43
Documents
54
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q apnu-20230331x10q.htm   iXBRL 10-Q 859100
2 EX-31.1 apnu-20230331xex31d1.htm EX-31.1 9241
3 EX-31.2 apnu-20230331xex31d2.htm EX-31.2 8483
4 EX-32.1 apnu-20230331xex32d1.htm EX-32.1 5555
5 EX-32.2 apnu-20230331xex32d2.htm EX-32.2 5049
  Complete submission text file 0001410578-23-001210.txt   4511739

Data Files

Seq Description Document Type Size
6 EX-101.SCH apnu-20230331.xsd EX-101.SCH 51053
7 EX-101.CAL apnu-20230331_cal.xml EX-101.CAL 21272
8 EX-101.DEF apnu-20230331_def.xml EX-101.DEF 204836
9 EX-101.LAB apnu-20230331_lab.xml EX-101.LAB 359716
10 EX-101.PRE apnu-20230331_pre.xml EX-101.PRE 282344
48 EXTRACTED XBRL INSTANCE DOCUMENT apnu-20230331x10q_htm.xml XML 663651
Mailing Address 175 FEDERAL STREET SUITE 875 BOSTON MA 02110
Business Address 175 FEDERAL STREET SUITE 875 BOSTON MA 02110 6179172603
Apeiron Capital Investment Corp. (Filer) CIK: 0001849011 (see all company filings)

IRS No.: 861963522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41030 | Film No.: 23922036
SIC: 2836 Biological Products, (No Diagnostic Substances)